Avia Logo

Products /

Biofourmis Connect

Biofourmis Connect

Biofourmis Connect

22 verified clients

Claimed

Overview


Select which hospital or health system you work at and see a personalized compatibility level.

Avia Summary

o
Biofourmis Connect is a solution provided by Biofourmis, Inc. which was founded in 2015. It belongs to multiple categories of digital health solutions including Digital Therapeutics (DTx), Care Transitions, and Consumer Access & Engagement.
o
It has 22 verified clients.
o
Biofourmis Connect integrates with major EMRs such as Not applicable.
o
Some other resource(s) that may be helpful in learning about Biofourmis Connect include: Biofourmis White Paper: How to successfully scale your RPM program and Top Digital Therapeutics Companies Report

DESCRIPTION

Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solutions provide people everywhere with connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, life science companies and patients alike, Biofourmis’ connected platform improves patient outcomes, accelerates drug development, and closes critical gaps in care—ultimately making science smarter, healthcare simpler, and patients healthier.

Read more
Product capabilities

Multimodal delivery options

Mobile patient apps Text Messaging Video Communication

AVIA GUIDE
What is multimodal delivery options?
Multimodal delivery options that allow patients to choose how to engage. Options include desktop, mobile apps, text messaging, and other connected devices.
EHR integration

Not applicable
Use case dependent
Not applicable
Desktop, Mobile / Tablet (web optimized), Mobile / Tablet (native app)
Use cases and differentiators

Digital clinical trials: Our technology-enabled, scalable clinical research platform supports trial decentralization, precision participant recruitment, and equitable access to treatment options for patients everywhere*.

Digital Drug Companions: We help our partners develop and commercialize novel digital companion technologies that enhance traditional drug therapies, such as digital biomarkers that track pain or identify cardiac events1,2.

Market Access Solutions: We offer care pathway integration for approved therapies to help ensure that patients have access to the right treatment when and where they need it.

 

 

None provided
Company information

Founded in 2015

463.6M total equity funding

Media


Images

No images provided

Videos

edit-media
Biofourmis DPharm Idol Winning Solution 2021
Downloads

No content provided

Reviews


Filter reviews


Overall Score

0 review


Sort by:
Most Recent
Sort by:
Most Recent
Oldest
Most Helpful

Filter reviews


Reviewer’s Rating
5
4
3
2
1

Reviewer’s Role
  • End user
  • Project manager
  • IT / Technical support
  • Executive sponsor
  • Internal consultant
  • Other

Reviewer’s Org Size
  • XL ($5B+ NPR)
  • L ($3-5B NPR)
  • M ($1-3B NPR)
  • S ($0.2-1B NPR)
  • XS (< $0.2B NPR)

Reviewer’s Org EMR compatibility

Reviewer’s Org Type
  • AMC
  • Pediatric Facilities
  • ACO
  • Rural Presence

Looking for reviews on Biofourmis Connect?

Submit your work email and we'll notify you when new reviews have been added.

Clients


Filter clients


Type
  • Partner

  • Vendor

  • Health System

  • Other

Explore Related Resources
back to top